Increased Interleukin 6 mRNA Expression by Peripheral Blood T Cells From Patients With IgA Nephropathy

References

• Emancipator SN, Lamm ME. IgA nephropathy: patho-genesis of the most common form of glomerulonephritis. Lab Invest 1989; 60: 168–183
   PubMed Web of Science ®Google Scholar
• Li HL, Hancock WW, Hoke DH, Dowling JP, Atkins RC. Mononuclear cell activation and decreased renal function in IgA nephropathy with crescents. Kidney Int 1990; 137: 1552–1556
   Google Scholar
• Arima S, Nakayama M, Naito M, Sato T, Takahashi K. Significance of mononuclear phagocytes in IgA nephropathy. Kidney Int 1991; 39: 684–692
   PubMed Web of Science ®Google Scholar
• Yano N, Miyazaki M, Endoh M, Kuramoto T, Eguchi K, Yagame M. Increase of CD23-positive cells in peripheral blood from patients with IgA nephropathy and non-IgA pro-liferative glomerulonephritis. Nephron 1992; 60: 404–410
   PubMed Web of Science ®Google Scholar
• Sato M, Kino K, Nabeshima K, Koshikawa S. Antilym-phocyte antibodies against CD4+ CD45R+ subsets in patients with IgA nephropathy. Nephron 1992; 160: 397–403
   Google Scholar
• Fortune F, Courteau M, Williams DG, Lehner T. T and B cell responses following immunization with tetanus toxoid in IgA nephropathy. Clin Exp Immunol 1992; 188: 62–67
   Google Scholar
• Parera M, Rivera F, Egido J, Campos A. The role of interleukin 2 (IL-2) and serum-soluble IL-2 receptor cells in idiopathic IgA nephropathy. Clin Immunol Immunopathol 1992; 63: 196–199
   PubMedGoogle Scholar
• Yano Y., Endoh M, Miyazaki M., Yamauchi F., Nomoto Y, Sakai H. Altered production of IgE and IgA induced by IL-4 in peripheral blood mononuclear cells from patients with IgA nephropathy. Clin Exp immunol 1992; 88: 295–300
   PubMed Web of Science ®Google Scholar
• Ebihara I, Nakamura T, Suzuki S, Tomino Y, Koide H. Protooncogene expression in peripheral blood mononuclear cells in IgA nephropathy. Kidney Int 1991; 39: 946–953
   PubMed Web of Science ®Google Scholar
• Nakamura T, Ebihara I., Takasaki Y, Tomino Y., Koide H. Increased expression of proliferating cell nuclear antigen mRNA in peripheral blood mononuclear cells from patients with IgA nephropathy. Am J Med Sci 1991; 302: 212–221
   Web of Science ®Google Scholar
• Nakamura T, Ebihara I, Nagaoka I, Tomino Y, Koide H. Activated peripheral blood mononuclear cells in IgA nephropathy express platelet-derived growth factor B-chain messenger RNA. J Lab Clin Med 1992; 120: 212–221
   PubMed Web of Science ®Google Scholar
• Wong GG, Clark SC. Multiple actions of interleukin-6 within a cytokine network. Immunol Today 1988; 9: 137–139
   PubMedGoogle Scholar
• Chiu CP, Moulds C, Coffman RL, Rennick D, Lee F. Multiple biological activities are expressed by a mouse interleukin-6 cDNA clone isolated from bone marrow stromal cells. Proc Natl Acad Sci USA 1988; 185: 7099–7103
   Google Scholar
• Le J, Vilcek J. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab invest 1989; 61: 588–602
   PubMed Web of Science ®Google Scholar
• Lahat N, Zlotnick AY, Shtiller R, Bar I, Merin G. Serum levels of IL-1, IL-6 and tumor necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol 1992; 89: 255–260
   PubMed Web of Science ®Google Scholar
• Hill DB, Marsano L, Cohen D., Allen J, Shedlofsky S, McClain CJ. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 1992; 119: 547–552
   PubMed Web of Science ®Google Scholar
• Sun Y., Tokushige K, Isono E, Yamauchi K, Obata H. Elevated serum interleukin-6 levels in patients with acute hepatitis. J Clin Immunol 1992; 12: 197–200
   PubMed Web of Science ®Google Scholar
• Pelton BK, Hylton W, Denman AM. Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol 1992; 89: 1251–254
   Web of Science ®Google Scholar
• Herbelin A, Urena P, Thu Nguyen A., Zingraff J, Descamps-Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 1991; 39: 954–960
   PubMed Web of Science ®Google Scholar
• Memoli B, Libetta C, Rampino T, Dal Canton A., Conte G, Scala G. Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 1992; 42: 320–326
   PubMed Web of Science ®Google Scholar
• Fukatsu A, Matsuo S, Tamai H, Sakamoto N, Matsuda T, Hirano T. Distribution of interleukin 6 in normal and diseased human kidney. Lab Invest 1991; 65: 61–66
   PubMed Web of Science ®Google Scholar
• Fukatsu A, Ito Y, Yuzawa Y, Yoshida F, Kato M., Miyakawa K. A case of POEMS syndrome showing elevated serum interleukin 6 and abnormal expression of interleukin 6 in the kidney. Nephron 1992; 62: 47–51
   PubMed Web of Science ®Google Scholar
• Tomino Y, Funabiki K, Ohmuro H, Shimizu M, Yokoyama K, Shirato I. Urinary levels of interleukin-6 and disease activity in patients with IgA nephropathy. Am J Nephrol 1991; 11: 459–464
   PubMed Web of Science ®Google Scholar
• Lee SMK, Rao VM, Franklin WA, Schiffer MS, Aronson AJ, Spargo Bh. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982; 13: 314–322
   PubMed Web of Science ®Google Scholar
• Hosoda K, Sakurabayashi I, Kawai T, Suzuki H, Maeda M, Tsuji A. Quantitative immunoassay for IgA class circulating immune complexes using solid phase Facb fragment of anti-C3. J Immunol Methods 1985; 82: 243–248
   PubMed Web of Science ®Google Scholar
• Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 1969; 21: 97–105
   Google Scholar
• Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. Cold Spring Harbor. Cold Spring Harbor Lab, New York 1989; 3–11
   Google Scholar
• Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6–13
   PubMed Web of Science ®Google Scholar
• Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H. Involvement of IL-6 in mesangial pro-liferative glomerulonephritis. J Immunol 1989; 143: 3949–3955
   PubMed Web of Science ®Google Scholar
• Gauldie J, Northemann W, Fey GH. IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. J Immunol 1990; 144: 3804–3808
   PubMed Web of Science ®Google Scholar
• Iwano M, Dohi K, Hirata E, Horii Y, Shiiki H, Ishikawa H. Induction of interleukin 6 synthesis in mouse glomeruli and cultured mesangial cells. Nephron 1992; 62: 58–65
   PubMed Web of Science ®Google Scholar
• Kishimoto T, Hirano T. Molecular regulation of the B lymphocyte response. Ann Rev Immunol 1988; 6: 485n512
   Web of Science ®Google Scholar
• Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 1991; 147: 117–123
   PubMed Web of Science ®Google Scholar
• Woloski B, Fuller G. Identification and partial characterization of hepatocyte-stimulating factor from leukemia cell lines: Comparison with interleukin 1. Proc Natl Acad Sci USA 1985; 82: 1443–1447
   PubMed Web of Science ®Google Scholar
• Aarden L., De Groot E, Schaap O., Lansdorp P. Production of hybridoma growth factor by monocytes. Eur J Immunol 1987; 17: 1411–1416
   PubMed Web of Science ®Google Scholar
• Akashi M, Loussararian AH, Adelman DC, Saito M., Koeffler HP. Role of lymphotoxin in expression of interleukin 6 in human fibroblasts. J Clin Invest 1990; 85: 121–129
   PubMed Web of Science ®Google Scholar
• Terebuh PD., Otterness IG, Strieter RM, Lincoln PM, Dan-forth LM, Kunkel SL. Biologic and immunohisto-chemical analysis of interleukin-6 expression in vivo. Constitutive and induced expression in murine polymor-phonuclear and mononuclear phagocytes. Am J Pathol 1992; 140: 649–657
   PubMed Web of Science ®Google Scholar
• Lotz M, Fink F, Kabouridis R, Tsoukas C, Hirano T, Kishimoto T. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocyte and T lymphocytes. J Exp Med 1988; 167: 1253–1258
   PubMed Web of Science ®Google Scholar
• Ceuppens JL, Baroja ML, Lorre K, van Damme J, Billiau A. Human T cell activation with phytohemagglutinin. The function of IL-6 on as accessory signal. J Immunol 1988; 141: 3868–3874
   PubMed Web of Science ®Google Scholar
• Noma T, Mitzuta T, Rosen A, Hirano T, Kishimoto T, Honjo T. Enhancement of the interleukin 2 receptor expression on T cells by multiple B lympholropic lymphokines. Immunol Lett 1987; 15: 249–253
   PubMed Web of Science ®Google Scholar
• Grossman RM, Krueger J, Yourish D, Granelli-Piperno A., Murphy PD, May LT. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 1989; 86: 6367–6370
   PubMed Web of Science ®Google Scholar
• Wood NC, Symons JA, Dickens E, Duff GW. In situ hybridization of IL-6 in rheumatoid arthritis. Clin Exp Immunol 1992; 87: 183–189
   PubMed Web of Science ®Google Scholar
• Kohase M, Henriksen-Destefano D, May L, Vilcek J, Sehgal PB. Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 1986; 45: 659–666
   PubMed Web of Science ®Google Scholar
• Horii Y, Muraguchi A, Suematsu S, Matsuda T, Yoshizaki K, Hirano T. Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol 1988; 141: 1529–1535
   PubMed Web of Science ®Google Scholar
• Jablons DM, Mule JJ, McIntosh JK, Sehgal PB, May LJ, Huang CM. IL-6/IFN-β-2 as a circulating hormone: induction by cytokine administration in humans. J Immunol 1989; 143: 1542–1545
   Google Scholar
• Abboud HE. Mononuclear cells, platelet-derived growth factor, and IgA nephropathy: what does it mean?. J Lab Clin Med 1992; 120: 181–183
   PubMed Web of Science ®Google Scholar
• Zanker B, Walz G, Wieder KJ, Strom TB. Evidence that glucocorticosteroids block expression of the human interleukin-6 gene by accessory cells. Transplantation 1990; 49: 183–185
   PubMed Web of Science ®Google Scholar